BridgeMD
New treatment option for Musculoskeletal Injury
Official title The Effects of AFO Heel Height and Stiffness on Gait
ClinicalTrials.gov ID: NCT04800484
What this study is testing
- What it's testing
- The proposed study evaluates the effect of ankle foot orthosis (AFO) heel height and stiffness on the forces and motion of the lower limb during over-ground walking in individuals who use an AFO for daily walking. Previous studies suggest that heel height and stiffness effect limb loading, but these data and the analysis techniques applied are limited.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- GROUP 1 Patient Ages: 18-70
- Daily AFO use to address unilateral, below knee functional deficits that result from limb injury or musculoskeletal disease (e.g. fracture, muscle...
- Greater than 2 weeks using their current AFO
- Ability to walk 50 feet without use of an assistive device (Cane, crutch, etc.)
- Ability to walk at a slow to moderate pace
You likely can't join if
- Pain \> 6/10 while walking during testing or an increase in pain during testing of \> 2/10.
- Central Nervous System disorder or disease (e.g. Stroke, Cerebral Palsy, Spinal Cord Injury, or other conditions that result in lower limb...
- Disorder or disease that affects peripheral nerve function (e.g. diabetes, Charcot Marie Tooth).
- Limited contralateral lower limb function due to injury or neurological/musculoskeletal disorder.
- Use of a hinged/articulating AFO (e.g. Plantar flexion stop, Dorsiflexion assist/stop, free motion), Charcot Restraint Orthotic Walker (CROW) boot...
- Use of an AFO that crosses the knee (Knee brace)
See the full eligibility criteria
Who can join
- GROUP 1 Patient Ages: 18-70
- Daily AFO use to address unilateral, below knee functional deficits that result from limb injury or musculoskeletal disease (e.g. fracture, muscle and/or nerve injury, ankle arthritis)
- Greater than 2 weeks using their current AFO
- Ability to walk 50 feet without use of an assistive device (Cane, crutch, etc.)
- Ability to walk at a slow to moderate pace
- AFO fits into traditional footwear
- Able to read and write in English and provide written informed consent GROUP 1 Patient
What rules you out
- Pain \> 6/10 while walking during testing or an increase in pain during testing of \> 2/10.
- Central Nervous System disorder or disease (e.g. Stroke, Cerebral Palsy, Spinal Cord Injury, or other conditions that result in lower limb spasticity).
- Disorder or disease that affects peripheral nerve function (e.g. diabetes, Charcot Marie Tooth).
- Limited contralateral lower limb function due to injury or neurological/musculoskeletal disorder.
- Use of a hinged/articulating AFO (e.g. Plantar flexion stop, Dorsiflexion assist/stop, free motion), Charcot Restraint Orthotic Walker (CROW) boot, AFOs that restrict all motion in the ankle and foot.
- Use of an AFO that crosses the knee (Knee brace)
- Insufficient space in shoe to accommodate the tallest heel wedge and their AFO
- Visual or hearing impairments that limit walking ability or could limit the ability to comply with instructions given during testing
- Pregnancy - Per participant self-report. Due the expected small number of pregnant individuals, and resulting inability to account for its effect on resulting outcomes participants will be withdrawn from the study.
- Body Mass index \> 40. GROUP 2 Patient Inclusion Criteria
- Ages: 18-70
- Daily AFO use to address below knee functional deficits that result from disease involving the peripheral nervous system (e.g. Charcot Marie Tooth, Multiple Sclerosis, diabetes)
- Greater than 2 weeks using their current AFO (unilateral or bilateral)
- Ability to walk 50 feet without use of an assistive device (Cane, crutch, etc.)
- AFO fits into traditional footwear
- Ability to walk at a slow to moderate pace
- Able to read and write in English and provide written informed consent GROUP 2 Patient Exclusion Criteria
- Pain \> 6/10 while walking or an increase in pain during testing of \> 2/10
- Central Nervous System disorder or disease (e.g. Stroke, Cerebral Palsy, Spinal Cord Injury, or other conditions that result in lower limb spasticity)
- Limited function due to limb injury (e.g. fracture, muscle and/or nerve injury)
- Use of a hinged/articulating AFO (e.g. Plantar flexion stop, Dorsiflexion assist/stop, free motion), Charcot Restraint Orthotic Walker (CROW) boot, AFOs that restrict all motion in the ankle and foot.
- Use of an AFO that crosses the knee (Knee brace)
- Insufficient space in shoe to accommodate the tallest heel wedge and their AFO
- Visual or hearing impairment that limit walking ability or limit the ability to comply with instructions given during testing
- Pregnancy - Per participant self-report. Due the expected small number of pregnant individuals, and resulting inability to account for its effect on resulting outcomes participants will be withdrawn from the study
- Body Mass index \> 40.
The study team makes the final eligibility decision.
Where it's taking place
- Iowa City, Iowa, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iowa City, Iowa, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.